Same Indication

Ipilimumab vs Lamotrigine

Ipilimumab vs Lamotrigine: Overview

This comparison examines the pharmacological differences between Ipilimumab and Lamotrigine.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Lamotrigine: Sodium channel blocker inhibiting glutamate release.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Lamotrigine — 25 hours.

Chemical Properties

Molecular Formula: Lamotrigine — C9H7Cl2N5.

Molecular Weight: Lamotrigine — 256.0910 g/mol.

Type: Ipilimumab — Antibody; Lamotrigine — Small molecule.